glp·helper
glphelper.com/zepbound/iowa/cedar-rapids
Dual GIP / GLP-1 receptor agonistFDA-approved November 2023Rx · Subcutaneous injection · Once weekly

Zepbound® providers &
prescriptions in Cedar Rapids, IA

Verified Zepbound providers in Cedar Rapids, IA. Checked against the NPI registry, sorted by waitlist, not by who pays us.[7]

average Zepbound weight loss →trial-anchored estimate
city providers
22
as of today
median wait
8d
first visit
telehealth
71%
of providers
cash range
$25 to $1,150
monthly
§ 02Provider directory: Iowa
22 of 22 shown

Find a Zepbound provider in Iowa.

Every entry is checked against the NPI registry and the Iowa medical board. Listings are ordered by current waitlist. The provider who can see you fastest appears first. We do not accept payment for placement.

Filter →
Type
Provider
City
Waitlist
Insurance
Browse by Iowa city · /zepbound/iowa/{city}
§ 03Getting Zepbound in Cedar Rapids
22 providers · Cedar Rapids, IA

How to get Zepbound in Cedar Rapids.

22 GLP-1 prescribers and 6 local resource types are on record for Cedar Rapids, plus 2 nearby towns in the directory.

Prescribers in Cedar Rapids
22 prescribers
22 GLP-1 prescribers in Cedar Rapids, most listed as Family Medicine (15), Internal Medicine (4) and Internal Medicine, Endocrinology, Diabetes & Metabolism (3). Any Iowa-licensed physician, nurse practitioner, or PA can prescribe Zepbound, over video or in person. The nearest towns on record are Davenport (25 providers) and Des Moines (35 providers).
Around the prescription in Cedar Rapids
6 listed nearby
6 dietitians, 6 gyms, 6 fitness clubs, 3 trainers, 6 physiotherapists and 6 places to move are on record near Cedar Rapids.
Medicaid (weight loss)
Diabetes only
As of April 2026, Iowa Medicaid covers GLP-1s for diabetes but not for weight loss. Employer and private plans can still cover them; that is a plan-design choice, not a state rule.

Medicaid status above is for weight-loss use and was compiled April 2026 from KFF and public Medicaid trackers; only 13 states cover it and several are mid-change, so confirm Iowa’s current Medicaid and plan rules before booking. GLPHelper provides information and provider matching, not medical or coverage advice.

§ 04Medication factsheet
cited · last review 2026.05.19

An injectable medication for chronic weight management in adults. Same molecule as Mounjaro.

Zepbound is the brand name Eli Lilly uses for tirzepatide approved for chronic weight management. It is a once-weekly subcutaneous injection and the first approved dual GIP/GLP-1 receptor agonist. The identical molecule, marketed as Mounjaro, is the FDA-approved formulation for type 2 diabetes.[2][3]

In SURMOUNT-1, adults with obesity (without diabetes) lost a mean of 20.9% of body weight on the 15 mg dose at 72 weeks, versus 3.1% with placebo. That is among the largest average weight reductions reported for an anti-obesity medication. Zepbound is approved as an adjunct to a reduced-calorie diet and increased physical activity.[1]

At a glanceMultiple (per dose)
Generic name
tirzepatide
Drug class
Dual GIP / GLP-1 receptor agonist
Manufacturer
Eli Lilly
FDA approved
November 2023
Approved use
Chronic weight management (adults with obesity, or overweight with a weight-related condition)
Off-label use
Type 2 diabetes (Mounjaro is the FDA-approved tirzepatide for diabetes)
Administration
Subcutaneous injection · Once weekly
Available doses
2.5 mg · 5 mg · 7.5 mg · 10 mg · 12.5 mg · 15 mg
Half-life
≈ 5 days
Pregnancy
Discontinue ≥ 2 months before a planned pregnancy; may reduce oral contraceptive efficacy

Community health · CDC

Weight & metabolic health in Iowa

Diagnosed diabetes reaches 9.9% of adults in Iowa.

of Iowa adults have obesity
36.6%
diagnosed diabetes
9.9%

Age-adjusted estimates for Iowa, community figures, not individual risk. CDC BRFSS 2024.

Estimate your weight lossweight regain after stopping
§ 05Support around Zepbound in Cedar Rapids
6 dietitians

The prescription is one part. Here is the rest, in Cedar Rapids.

Trials of tirzepatide paired the drug with diet counseling and regular activity. Every name below is a real listing near Cedar Rapids, IA, ordered as the registry lists them, never by who pays us.

Registered dietitians

A registered dietitian builds the food plan around your prescription. Call to ask about GLP-1 nutrition plans and insurance.

Alicia Aguiar, M.S., R.D., L.D
RD
Registered dietitian
1556 1St Ave Ne
Call 319-364-4196NPI 1316384043
Rachael Biggers, RD
RD
Registered dietitian
1002 4Th Ave Se
Call 319-298-2246NPI 1154834612
Kira Blum, RDN, LD
RD
Registered dietitian
930 Evashevski Dr.
Call 319-325-4079NPI 1891338539
Alisa Christoffel, R.D., L.D
RD
Registered dietitian
20 Wilson Ave Sw
Call 319-366-2700NPI 1104286749
Sara Claeys
RD
Registered dietitian
1002 4Th Ave Se
Call 319-363-3565NPI 1194133736
Teresa Clark, RD, LD
RD
Registered dietitian
526 Southgate Ave
Call 319-354-3824NPI 1568576718

Gyms near you

A gym gives you the regular movement that keeps muscle while the weight comes off.

Planet Fitness
GYM
4.4 on Google · 669 reviews
383 Edgewood Rd NW
Website
iGYM
GYM
4.7 on Google · 310 reviews
1100 Blairs Ferry Rd NE
Website
House of Iron Downtown
GYM
5.0 on Google · 185 reviews
316 3rd Ave SE
Website
YMCA
GYM
4.2 on Google · 184 reviews
3740 Irish Dr
Website
Anytime Fitness
GYM
4.0 on Google · 151 reviews
501 7th Ave
Website
Orangetheory Fitness
GYM
4.9 on Google · 144 reviews
4824 1st Ave NE
Website
§ 06Clinical evidence
STEP 1 to 4 + SELECT (N = 17,604)

What the trials actually showed.

We summarize the SURMOUNT weight-management program. Figures are means at the 72-week primary endpoint, by dose.

SURMOUNT-1 randomized 2,539 adults with obesity (without diabetes) across 72 weeks. Mean weight change was −15.0% (5 mg), −19.5% (10 mg), and −20.9% (15 mg) versus −3.1% with placebo. A majority of patients on the higher doses lost ≥20% of body weight.[2]
STEP / SELECT endpoint table2.4 mg / 68 wk
Mean weight change (15 mg)
−20.9%
SURMOUNT-1, 72 wk vs −3.1% placebo[2]
Mean weight change (10 mg)
−19.5%
SURMOUNT-1, 72 wk[2]
Mean weight change (5 mg)
−15.0%
SURMOUNT-1, 72 wk[2]
Effect size varies with baseline characteristics and adherence. Individual response may differ materially.
average Zepbound weight loss →mapped to your starting weight
§ 07Safety & adverse events
from FDA label, sect. 6.1

Most side effects are gastrointestinal and resolve within weeks.

The most common adverse events in STEP trials were nausea (44%), diarrhea (30%), and vomiting (24%), more frequent at the 2.4 mg dose than at Ozempic doses, but typically transient.[1] Serious events were rare but include pancreatitis, gallbladder disease, and an FDA boxed warning regarding thyroid C-cell tumors based on rodent data.[8]

Boxed warning. Boxed warning: risk of thyroid C-cell tumors. Contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN-2).
Effect
Frequency
Severity
Note
Nausea
12 to 24%
mild
Dose-dependent; usually eases after titration
Diarrhea
12 to 19%
mild
More frequent during dose escalation
Vomiting
5 to 13%
mild
Reduced by slower titration
Constipation
6 to 17%
mild
Decreased appetite
5 to 11%
mild
Expected pharmacologic effect
Pancreatitis
<0.3%
serious
Discontinue if acute pancreatitis is suspected
Gallbladder disease
~1 to 2%
serious
Cholelithiasis risk rises with rapid weight loss
Thyroid C-cell tumors
rodent data
boxed warning
Contraindicated with MTC or MEN-2 history
§ 08Cost & coverage, published, not gated
USD · monthly

Most directories hide the price. We don't.

Cash prices vary roughly 50× between the brand-name retail rate and a manufacturer savings card. The number you actually pay depends on your insurance plan, your diagnosis code, and which pharmacy fills the script. Here are the ranges, plainly.

Data sources: GoodRx national retail survey[6], CMS Part D formulary files[5], Novo Nordisk patient access program.

Zepbound cash price (no insurance)
$1,000 to $1,300
per month
Brand-name retail; Lilly self-pay vials lower for some doses[6]
Commercial insurance (weight)
Often denied
On-label for obesity but frequently requires prior authorization
Medicare Part D
Not covered
Weight-loss indication not covered by law[5]
Manufacturer savings card
as low as $25
per month
Commercial insurance with coverage only; eligibility limits apply
Updated weekly · last fetch 2026-05-18 04:00 UTCCost methodology →
Find Zepbound providers in Iowa

NPI-verified Zepbound (tirzepatide) prescribers and clinics, ordered by availability, never by who pays us.

Zepbound in other states

Find NPI-verified Zepbound (tirzepatide) doctors, clinics, and pharmacies in the states we cover, ordered by availability, never by who pays us.

Related GLP-1 research
§ 09Frequently asked: Zepbound in Iowa

The questions people ask before they book.

Answers reviewed by the GLPHelper Medical Team. Citations link to primary sources, never marketing copy.

Zepbound and Mounjaro are both tirzepatide, made by Eli Lilly, but they carry different FDA-approved indications. Zepbound is approved for chronic weight management; Mounjaro is approved for type 2 diabetes. Insurers treat them as separate products, and weight-loss coverage is far more restricted than diabetes coverage.[1]